Literature DB >> 19294574

Constitutive neuronal expression of the immune regulator, programmed death 1 (PD-1), identified during experimental autoimmune uveitis.

Ling Chen1, Vicky Pai, Ralph Levinson, Arlene H Sharpe, Gordon J Freeman, Jonathan Braun, Lynn K Gordon.   

Abstract

PURPOSE: Programmed death-1 (PD-1) ligation downregulates active lymphocyte responses. The authors tested whether PD-1 or its ligands are expressed in the posterior segment during active intraocular inflammation.
METHODS: Experimental autoimmune uveitis (EAU) was induced using interphotoreceptor retinoid-binding protein (IRBP 161-180). Ocular inflammation was evaluated by histology and expression of PD-1 ligand tested by immunohistochemistry. PD-1 expression was evaluated by immunohistochemistry, RT-PCR, and Western immunoblotting.
RESULTS: Using immunohistochemistry, PD-1, but not its ligands, was constitutively expressed in retinal neurons of naive mouse retina. Both PD-1 and its ligands were observed, as expected, in sites of active inflammation.
CONCLUSIONS: PD-1 and its ligands were expressed in sites of active inflammation, in accordance with many other models of inflammatory disease. Surprisingly, PD-1, not previously described outside the immune system, was constitutively expressed in retinal neurons, raising the possibility that PD-1 signaling may be important for neuronal function in the absence of an inflammatory insult.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19294574     DOI: 10.1080/09273940802491884

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.728


  15 in total

1.  Immunization with different viral antigens alters the pattern of T cell exhaustion and latency in herpes simplex virus type 1-infected mice.

Authors:  Sariah J Allen; Kevin R Mott; Mandana Zandian; Homayon Ghiasi
Journal:  J Virol       Date:  2010-09-22       Impact factor: 5.103

Review 2.  Immune checkpoints in central nervous system autoimmunity.

Authors:  Nicole Joller; Anneli Peters; Ana C Anderson; Vijay K Kuchroo
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

3.  Programmed cell death-1 is expressed in large retinal ganglion cells and is upregulated after optic nerve crush.

Authors:  Wei Wang; Ann Chan; Yu Qin; Jacky M K Kwong; Joseph Caprioli; Ralph Levinson; Ling Chen; Lynn K Gordon
Journal:  Exp Eye Res       Date:  2015-08-13       Impact factor: 3.467

4.  Bilateral uveitis associated with nivolumab therapy for metastatic melanoma: a case report.

Authors:  Daniel Russell Richardson; Brian Ellis; Inderjit Mehmi; Monique Leys
Journal:  Int J Ophthalmol       Date:  2017-07-18       Impact factor: 1.779

5.  Programmed death-1 pathway limits central nervous system inflammation and neurologic deficits in murine experimental stroke.

Authors:  Xuefang Ren; Kozaburo Akiyoshi; Arthur A Vandenbark; Patricia D Hurn; Halina Offner
Journal:  Stroke       Date:  2011-07-07       Impact factor: 7.914

6.  Neuronal programmed cell death-1 ligand expression regulates retinal ganglion cell number in neonatal and adult mice.

Authors:  Caroline W Sham; Ann M Chan; Jacky M K Kwong; Joseph Caprioli; Steven Nusinowitz; Bryan Chen; Janice G Lee; Nishant M Gandhi; Loise M Francisco; Arlene H Sharpe; Ling Chen; Jonathan Braun; Lynn K Gordon
Journal:  J Neuroophthalmol       Date:  2012-09       Impact factor: 3.042

7.  Role of the immune modulator programmed cell death-1 during development and apoptosis of mouse retinal ganglion cells.

Authors:  Ling Chen; Caroline W Sham; Ann M Chan; Loise M Francisco; Yin Wu; Sergey Mareninov; Arlene H Sharpe; Gordon J Freeman; Xian-Jie Yang; Jonathan Braun; Lynn K Gordon
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-05-06       Impact factor: 4.799

8.  Clinical Update on Checkpoint Inhibitor Therapy for Conjunctival and Eyelid Melanoma.

Authors:  Jonathan E Lu; Jessica R Chang; Jesse L Berry; Gino K In; Sandy Zhang-Nunes
Journal:  Int Ophthalmol Clin       Date:  2020

Review 9.  Inflammatory CNS disease caused by immune checkpoint inhibitors: status and perspectives.

Authors:  Lidia M Yshii; Reinhard Hohlfeld; Roland S Liblau
Journal:  Nat Rev Neurol       Date:  2017-11-06       Impact factor: 42.937

10.  PD-1 is required to maintain stem cell properties in human dental pulp stem cells.

Authors:  Yao Liu; Huan Jing; Xiaoxing Kou; Chider Chen; Dawei Liu; Yan Jin; Li Lu; Songtao Shi
Journal:  Cell Death Differ       Date:  2018-02-22       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.